无细胞线粒体DNA-TLR9信号激活介导慢性应激诱导的社交行为缺陷
该研究在小鼠慢性束缚应激模型中观察到血清无细胞线粒体DNA(cf-mtDNA)水平显著升高,全身性DNase I治疗可减轻应激诱导的社交行为缺陷。研究进一步提示线粒体自噬和MAVS参与介导cf-mtDNA水平变化及社交行为,抑制TLR9可减轻mtDNA诱导的社交行为缺陷,表明cf-mtDNA-TLR9信号在应激诱导社交行为缺陷中起关键作用。
要点
- 慢性束缚应激使小鼠血清cf-mtDNA水平显著升高。
- 全身性DNase I治疗减轻慢性束缚应激诱导的社交行为缺陷。
- 抑制TLR9减轻mtDNA诱导的社交行为缺陷。
核心结论
- cf-mtDNA-TLR9信号在介导慢性应激诱导的社交行为缺陷中起关键作用。
研究设计与样本
- 研究采用小鼠慢性束缚应激(RS)模型,检测血清cf-mtDNA水平并观察DNase I、线粒体自噬、MAVS及TLR9抑制对社交行为的影响。
主要发现
- 慢性束缚应激诱导小鼠血清cf-mtDNA水平显著升高。
- 全身性DNase I治疗减轻RS诱导的社交行为缺陷。
- 线粒体自噬和MAVS可能参与介导慢性应激诱导的cf-mtDNA水平变化及社交行为。
- 抑制TLR9减轻mtDNA诱导的社交行为缺陷。
临床怎么用
- 该发现提示cf-mtDNA-TLR9信号可作为应激相关社交行为缺陷的潜在干预靶点,但尚需临床研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Inflammation and social behavior deficits are associated with a number of neuropsychiatric disorders. Chronic stress, a major risk factor for depression and other mental health conditions is known to increase inflammatory responses and social behavior impairments. Disturbances in mitochondria function have been found in chronic stress conditions, however the mechanisms that link mitochondrial dysfunction to stress-induced social behavior deficits are not well understood. In this study, we found that chronic restraint stress (RS) induces significant increases in serum cell-free mitochondrial DNA (cf-mtDNA) levels in mice, and systemic Deoxyribonuclease I (DNase I) treatment attenuated RS-induced social behavioral deficits. Our findings revealed potential roles of mitophagy and Mitochondrial antiviral-signaling protein (MAVS) in mediating chronic stress-induced changes in cf-mtDNA levels and social behavior. Furthermore, we showed that inhibition of Toll-like receptor 9 (TLR9) attenuates mtDNA-induced social behavior deficits. Together, these findings show that cf-mtDNA-TLR9 signaling is critical in mediating stress-induced social behavior deficits.
引用
- Tripathi A, Bartosh A, Whitehead C, et al. Activation of cell-free mtDNA-TLR9 signaling mediates chronic stress-induced social behavior deficits. Mol Psychiatry. 2023. PMID: 37528226. doi:10.1038/s41380-023-02189-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。